APRILE, LARA
 Distribuzione geografica
Continente #
NA - Nord America 1.897
EU - Europa 1.532
AS - Asia 795
SA - Sud America 92
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 3
Totale 4.393
Nazione #
US - Stati Uniti d'America 1.868
GB - Regno Unito 375
RU - Federazione Russa 356
CN - Cina 256
SG - Singapore 252
IE - Irlanda 198
IT - Italia 159
VN - Vietnam 131
SE - Svezia 101
UA - Ucraina 99
DE - Germania 92
BR - Brasile 70
FR - Francia 68
HK - Hong Kong 46
FI - Finlandia 30
ZA - Sudafrica 26
KR - Corea 23
IN - India 21
CA - Canada 14
PL - Polonia 13
BD - Bangladesh 11
MX - Messico 10
JP - Giappone 9
IQ - Iraq 8
ES - Italia 7
AR - Argentina 5
BE - Belgio 5
MY - Malesia 5
TR - Turchia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
LT - Lituania 4
NG - Nigeria 4
NL - Olanda 4
PT - Portogallo 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EC - Ecuador 3
ID - Indonesia 3
IR - Iran 3
PK - Pakistan 3
DK - Danimarca 2
KE - Kenya 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
SM - San Marino 2
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.361
Città #
Southend 335
Dallas 240
Dublin 197
Fairfield 160
Singapore 140
Ashburn 125
Chandler 111
Woodbridge 102
San Jose 95
Moscow 91
Santa Clara 90
Jacksonville 80
Wilmington 69
Beijing 68
Ann Arbor 61
Houston 59
Seattle 54
Milan 48
Cambridge 45
Ho Chi Minh City 45
Hong Kong 43
Council Bluffs 42
The Dalles 42
Hanoi 39
New York 34
Nanjing 32
Princeton 32
Los Angeles 28
Hefei 24
Johannesburg 24
Seoul 23
Siena 20
Lauterbourg 18
Munich 14
Boardman 13
Helsinki 13
Orem 13
São Paulo 12
Shanghai 11
Figino 10
Nanchang 10
Poplar 10
Warsaw 10
Atlanta 9
Buffalo 9
Columbus 9
Nuremberg 9
Tokyo 9
Chennai 8
Da Nang 8
Dong Ket 8
London 8
Florence 7
San Mateo 7
Zhengzhou 7
Brooklyn 6
Denver 6
Hebei 6
Mexico City 6
San Diego 6
San Francisco 6
Tianjin 6
Brussels 5
Montreal 5
Phoenix 5
Rome 5
Shenyang 5
Stockholm 5
Abuja 4
Baghdad 4
Boston 4
Cagliari 4
Chicago 4
Frankfurt am Main 4
Guangzhou 4
Haiphong 4
Norwalk 4
Poggibonsi 4
Taizhou 4
Tashkent 4
Ankara 3
Augusta 3
Brno 3
Caracas 3
Cascavel 3
Changsha 3
Curitiba 3
Düsseldorf 3
Hangzhou 3
Hyderabad 3
Lisbon 3
New Delhi 3
Newark 3
Redondo Beach 3
Tunis 3
Vienna 3
Arezzo 2
Arienzo 2
Bari 2
Bengaluru 2
Totale 3.006
Nome #
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 296
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 291
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 277
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 264
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial 257
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 254
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination 248
Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients. 236
Peptide vaccines for hematological malignancies: a missed promise? 236
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation 232
Flow-cytometry evaluation of residual Leukemia Stem Cells in Chronic Myeloid Leukemia patients: feasibility and clinical application. 227
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 225
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. 218
FLT3 inhibitors in the management of acute myeloid leukemia 218
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion 188
Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy 184
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 178
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 139
null 130
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study 95
Totale 4.393
Categoria #
all - tutte 12.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022205 0 16 12 27 14 11 11 7 10 27 23 47
2022/2023359 19 30 48 52 31 79 1 33 35 5 17 9
2023/2024275 12 7 27 4 5 75 109 11 0 5 2 18
2024/2025485 6 19 62 19 72 21 5 23 70 14 64 110
2025/20261.618 97 195 158 212 367 64 209 33 43 97 29 114
2026/202772 41 31 0 0 0 0 0 0 0 0 0 0
Totale 4.393